Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

Reducing immunosuppressant use in patients with chronic inflammation during the COVID‐19 pandemic: Risks versus benefits

Bibliographic Details
Main Authors:	Mariko Ogawa‐Momohara, Yoshinao Muro, Takuya Takeichi, Masashi Akiyama
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-10-01
Series:	Journal of Cutaneous Immunology and Allergy
Online Access:	https://doi.org/10.1002/cia2.12132

Similar Items

ANCA‐associated neuropathy in systemic sclerosis: A case report and review of literature
by: Kayo Takenaka, et al.
Published: (2021-04-01)

Late‐onset Langerhans cell histiocytosis without extracutaneous involvement
by: Mai Iwata, et al.
Published: (2020-08-01)

Deep Phenotyping of Superficial Epidermolytic Ichthyosis due to a Recurrent Mutation in <i>KRT2</i>
by: Yuika Suzuki, et al.
Published: (2022-07-01)

Two Cases of Porokeratosis with MVD Mutations, in Association with Bullous Pemphigoid
by: Yuki Arisawa, et al.
Published: (2021-03-01)

KLICK Syndrome Linked to a POMP Mutation Has Features Suggestive of an Autoinflammatory Keratinization Disease
by: Takuya Takeichi, et al.
Published: (2020-04-01)

UVB-Induced Skin Autoinflammation Due to Nlrp1b Mutation and Its Inhibition by Anti-IL-1β Antibody
by: Yuya Murase, et al.
Published: (2022-06-01)

Frequent <i>FOXA1</i>-Activating Mutations in Extramammary Paget’s Disease
by: Takuya Takeichi, et al.
Published: (2020-03-01)

Revertant mutation releases confined lethal mutation, opening Pandora's box: a novel genetic pathogenesis.
by: Yasushi Ogawa, et al.
Published: (2014-05-01)

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression
by: Olaf Tyc, et al.
Published: (2023-08-01)

Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
by: Russell B. Hawkins, et al.
Published: (2018-07-01)

LP-060 Extracellular vesicular proteins in plasma from patients with cutaneous lupus correlate with disease activity
by: Mariko Momohara
Published: (2023-07-01)

A Japanese Case of Galli-Galli Disease due to a Previously Unreported POGLUT1 Mutation
by: Michihiro Kono, et al.
Published: (2019-01-01)

Silica-induced Chronic Inflammation Promotes Lung Carcinogenesis in the Context of an Immunosuppressive Microenvironment
by: Javier Freire, et al.
Published: (2013-08-01)

Ceramide Analysis in Combination With Genetic Testing May Provide a Precise Diagnosis for Self-Healing Collodion Babies
by: Takuya Takeichi, et al.
Published: (2022-12-01)

Dietary cucurbitacin E reduces high-strength altitude training induced oxidative stress, inflammation and immunosuppression
by: HEZHI XIE, et al.
Published: (2020-11-01)

PROFILE OF PRO AND ANTI-INFLAMMATORY CYTOKINES IN PATIENTS WITH CHRONIC LIVER DISEASE IN THE COMPENSATION, INFLAMMATION AND IMMUNOSUPPRESSION PHASES
by: B. Tijerina-Soto, et al.
Published: (2022-01-01)

Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
by: Fenella Barlow-Pay, et al.
Published: (2021-02-01)

Oral-Intestinal Microbiota in Colorectal Cancer: Inflammation and Immunosuppression
by: Mo S, et al.
Published: (2022-02-01)

Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndrome
by: Pepijn van Houten, et al.
Published: (2023-07-01)

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
by: Ayodeji Adegunsoye, et al.
Published: (2017-08-01)

Development of severe fingertip ulcers, pulmonary hypertension, and scleroderma renal crisis in a patient with systemic sclerosis and anti‐PL12 antibodies
by: Akiko Kaneshima, et al.
Published: (2023-02-01)

Autoinflammatory Keratinization Disease With Hepatitis and Autism Reveals Roles for JAK1 Kinase Hyperactivity in Autoinflammation
by: Takuya Takeichi, et al.
Published: (2022-01-01)

Challenges in managing immunosuppressive therapies for psoriasis during the COVID-19 pandemic
by: K. Desai, et al.
Published: (2020-05-01)

Clinicians’ and Researchers’ Views on Precision Medicine in Chronic Inflammation: Practices, Benefits and Challenges
by: Anke Erdmann, et al.
Published: (2022-04-01)

ICU-Acquired Hypernatremia Is Associated with Persistent Inflammation, Immunosuppression and Catabolism Syndrome
by: Christopher Rugg, et al.
Published: (2020-09-01)

Cerebral Amyloid Angiopathy-Related Inflammation in the Immunosuppressed: A Case Report
by: Thomas Nelson, et al.
Published: (2019-12-01)

Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
by: Jinlin Zhang, et al.
Published: (2022-07-01)

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh
by: Md Jahidul Hasan, et al.
Published: (2022-12-01)

Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation
by: Marlies Cortés, et al.
Published: (2023-11-01)

Assistance and health care provided to adolescents with chronic and immunosuppressive conditions in a tertiary university hospital during the COVID-19 pandemic
by: Sofia S.M. Lavorato, et al.
Published: (2021-03-01)

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
by: Iria Fernandez Botana, et al.
Published: (2023-12-01)

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
by: Joaquin Miguel Pellegrini, et al.
Published: (2022-06-01)

Disseminated Intravascular Coagulopathy Is Associated with the Outcome of Persistent Inflammation, Immunosuppression and Catabolism Syndrome
by: Kensuke Nakamura, et al.
Published: (2020-08-01)

Immunosuppressive MDSCs Induced by TLR Signaling During Infection And Role In Resolution of Inflammation
by: ANURADHA eRAY, et al.
Published: (2013-09-01)

Correction: Biomarkers of Inflammation, Immunosuppression and Stress Are Revealed by Metabolomic Profiling of Tuberculosis Patients.
by: PLOS ONE Staff
Published: (2016-01-01)

The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
by: Ki Hong Choi, et al.
Published: (2019-09-01)

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
by: Xu L, et al.
Published: (2023-02-01)

Inflammation and cancer
by: Mariko Murata
Published: (2018-10-01)

Pet ownership and lifestyle behaviours of immunosuppressed individuals and their relatives in the context of COVID-19 pandemic
by: Audrey Plante, et al.
Published: (2023-06-01)

The Potential Benefit of Hydroxychloroquine in Chronic Placental Inflammation of Unknown Etiology Associated with Adverse Pregnancy Outcomes
by: Alexandra Bouariu, et al.
Published: (2022-01-01)